INFORMED, which stands for Information Exchange and Data Transformation, will investigate the best ways to integrate data science into regulatory decision-making, with an initial focus on digital health and advanced analytics related to cancer.
Here are three initial projects under the INFORMED umbrella.
1. A collaboration with Project Data Sphere, a nonprofit open-access cancer data repository, to develop algorithms that use medical imaging data to classify tumor dynamics.
2. A joint fellowship program with the National Cancer Institute at the National Institutes of Health to develop digital biomarkers as drug development tools.
3. A fellowship program with Cambridge, Mass.-based Harvard University focused on developing and implementing artificial intelligence and machine learning algorithms for regulatory science applications.
More articles on supply chain:
Commissioner Dr. Scott Gottlieb says FDA is ‘actively developing’ regulatory framework for AI technologies
McKesson adds Medtronic exec as independent director: 4 takeaways
FDA approves first drug for rare form of rickets: 3 things to know
